期刊文献+

吡格列酮对高糖诱导大鼠腹膜间皮细胞合成细胞外基质的作用及机制 被引量:1

Effect and mechanism of pioglitazone on the extracellular matrix production of rat peritoneal mesothelial cells induced by high glucose
原文传递
导出
摘要 目的观察过氧化物酶体增殖物活化受体1配体吡格列酮对高糖作用下大鼠腹膜间皮细胞(RPMC)合成细胞外基质的作用以及调节机制。方法胰蛋白酶消化法分离培养RPMC。随机分为正常对照组、高糖组(2.5%葡萄糖)、吡格列酮干预组(10μmol/L、20μmol/L+2.5%葡萄糖)、二硫氨基甲酸吡咯烷干预组(PDTC,NF—KB抑制剂,25tzmol/L、50μmol/L+2.5%葡萄糖)、姜黄素干预组『活化蛋白1(AP-1)抑制剂,15μmol/L、30μmol/L+2.5%葡萄糖1。RT—PCR方法检测纤连蛋白(FN)、I型胶原(COLI)、纤溶酶原激活抑制因子1(PAI-1)、c—fos、c—junmRNA表达。ELISA方法检测细胞上清液中FN、COLI和PAI-1蛋白水平。Western印迹方法检测IKB(x、磷酸化IκBα(p-IκBα)、NF—κBp65、磷酸化NF—κBp65(p-p65)蛋白表达。结果常规培养的腹膜间皮细胞表达基础量的FN、COLI和PAI-1,高糖显著上调其蛋白及mRNA表达(P〈0.01)。吡格列酮预处理后,高糖诱导的FN、COLI和PAI-1蛋白及mRNA表达显著低于高糖组(P〈0.01)。高糖作用后,磷酸化IKBα和NF—κBp65水平显著增高,c—fos、c—junmRNA表达增加,与对照组差异有统计学意义(P〈0.01)。PDTC预处理后,高糖诱导RPMC的FN和PAI-1蛋白水平降低(P〈0.01),COLI蛋白表达无明显变化。AP-1抑制剂姜黄素预处理后,高糖诱导的RPMCFN、COLI和PAI-1蛋白水平均显著降低,与对照组差异有统计学意义(P〈0.01)。吡格列酮抑制高糖条件下磷酸化IKBα和NF-κBp65水平,抑制c—fos、c—junmRNA表达(P〈0.05或P〈0.01)。结论NF—κB和AP-1信号通路参与高糖条件下RPMC的FN、COLI和PAI-1表达的调节。吡格列酮通过NF—κB和AP-1途径下调高糖诱导的RPMC的FN、COLI和PAI-1的表达,从而发挥抗纤维化作用。 Objective To study the effect and underlying mechanism of pioglitazone (PPARγ, ligand) on increased extracellular matrix (ECM) production in rat peritoneal mesothelial cells (RPMCs) induced by high glucose. Methods RPMCs were isolated and subeuhured by enzymatic disaggregation. The cells were randomly divided into groups as follows: normal control group,high glucose group (2.5%glucose), PDTC group (NF-KB inhibitor, 25 μmol/L and 50 μmol/L+ 2.5%glucose), curcumin group (activator protein-1 inhibitor, 15 μmol/L and 30 μmol/L+2.5% glucose) and pioglitazone group (10 μmol/L and 20 μmol/L+2.5%glucose). RT-PCR was used todetect the mRNA expression of fibronectin (FN), collagen I (COL I ), plasminogen activator inhibitor-1 (PAI-1), c-fos and c-jun. The protein expression of p-IKBα, IKBα, p-p65, NF-KBp65 was estimated by Western blotting. Concentrations of FN, COL I and PAI-1 in culture medium were examined by ELISA. Results The expressions of FN, COL I and PAI-1 in RPMCs were significantly increased after treatment with high glucoce (P〈0.01) and significantly decreased after treatment with pioglitazone (P〈0.01). High glucose up-regulated th phosphoralation of IKBα, NF-κBp65 and the expression of c-fos and c-jun mRNA. Both PDTC and curcumin reduced the protein expression of FN and PAI-1 in RPMCs induced by high glucose (P〈0.01), not PDTC but curcumin decreased the protein expression of COL I (P〈0.01). Pioglitazone partially reversed the effect of high glucose on the phosphoralation of IKBα NF-κBp65 and the mRNA expression of c-fos and c-jun (P〈0.01). Conclusion Pioglitazone can suppress the increased ECM production in RPMCs induced by high glucose, and this effect might be related to the inhibitory effects on activation of NF-κB and activator protein-1 pathways.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2010年第3期198-203,共6页 Chinese Journal of Nephrology
关键词 腹膜 细胞外基质 NF—κB 活化蛋白1 过氧化物酶体增殖物 激活受体γ Peritoneum Extracellular matrix NF-kappa B Activator protein- 1 Peroxisome proliferators-activated receptor-γ
  • 相关文献

参考文献22

  • 1Dobbie JW.Peritoneal ultrastructure and changes with continuous ambulatory peritoneal dialysis.Perit Dial Int,1993,13 Suppl:S585-S587. 被引量:1
  • 2Panchapakesan U,Pollock CA,Chen XM.The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.Am J Physiol Renal Physiol,2004,287:F528-F534. 被引量:1
  • 3Tanimoto M,Fan Q,Gohda T,et al.Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.Metabolism,2004,53:1473-1479. 被引量:1
  • 4Zhang YF,Yang X,Zhang YJ,et al.Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells:its potential role in peritoneal cavity local defense.Am J Nephrol,2006,26:602-611. 被引量:1
  • 5Yung S,Liu ZH,Lai KN,et al.Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor betal and fibronectin by human peritoneal mesothelial cells.Perit Dial Int,2001,21 Suppl:S41-S47. 被引量:1
  • 6Katsutani M,Ito T,Masaki T,et al.Glucose-based PD solution,but not icodextrin-based PD solution,induces plasminogen activator inhibitor-1 and tissue-type plasminogen activator in human peritoneal mesothelial cells via ERK1/2.Ther Apher Dial,2007,11:94-100. 被引量:1
  • 7Berrou.J,Tostivint I,Verrecchia F,et al.Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.Int J Mol Med,2009,23:513-520. 被引量:1
  • 8Chen S,Mukherjee S,Chakraborty C,et al.High glucose induced,endothelin-dependent fibronectin synthesis is mediated via NF-kappaB and AP-1.Am J Physiol Cell Physiol,2003,284:C263-C272. 被引量:1
  • 9Irita J,Okura T,Kurata M,et al.Osteopontin in rat renal fibroblasts:functional properties and transcriptional regulation by aldosterone.Hypertension,2008,51:507-513. 被引量:1
  • 10Lee SK,Kim BS,Yang WS,et al.High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells.Kidney Int,2001,60:55-64. 被引量:1

二级参考文献38

  • 1孙正达,马骥,顾勇,林善锬.吡咯列酮对单肾切除的糖尿病大鼠肾脏纤维化的作用[J].复旦学报(医学版),2003,30(3):235-238. 被引量:4
  • 2Isono M, Cruz MC, Chen S, et al. Extracellular signal-regulated kinase mediates stimulation TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol, 2000, 11: 2222-2230. 被引量:1
  • 3Renard P, Raes M. The proinflammatory transcription factor NFkappa B: a potential target for novel therapeutical strategies.Cell Biol Toxicol, 1999, 15: 341-344. 被引量:1
  • 4Kristina S, Bart S, Johan A. The peroxisome proliferators activiators (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta, 1996, 1302:93-109. 被引量:1
  • 5Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes, 2002, 49:1022-1032. 被引量:1
  • 6Nakamura T, Ushiyama C, Ahimada N, et al. Comparative effects of pioglitazone glibenclamide and voglibose on urinary endothelin-1and albumin excretion in diabetes patients. J Diabetes Complications, 2000, 14: 250-254. 被引量:1
  • 7Ma LJ, Marcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nodiabetic glomerulosclerosis in rats. Kidney Int, 2001, 59:1899-1910. 被引量:1
  • 8Mei CL, Zhang LM, Chen L. The establishment and identification of rat glomelular mesangial cell line. Clin J Nephrol Dial Transplant, 1996, 5: 90-92. 被引量:1
  • 9Spiegelman BM. PPARγ: adipogenic regulator and thiazolidinedione receptor. Diabetes, 1998, 47: 507-514. 被引量:1
  • 10Jiang C, Ting AT, Seed B. PPARγ agonists inhibits production of monocyte inflammatory cytokines. Nature, 1998, 391: 82-86. 被引量:1

共引文献8

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部